Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2018 | 70 | 0.71 | Why? |
| Analgesics | 2 | 2018 | 451 | 0.65 | Why? |
| Hypnotics and Sedatives | 2 | 2018 | 624 | 0.60 | Why? |
| Psychomotor Agitation | 1 | 2017 | 208 | 0.60 | Why? |
| Cultural Diversity | 1 | 2018 | 220 | 0.60 | Why? |
| Cross-Cultural Comparison | 1 | 2018 | 338 | 0.59 | Why? |
| Professionalism | 1 | 2017 | 171 | 0.57 | Why? |
| Withholding Treatment | 1 | 2018 | 798 | 0.46 | Why? |
| Delirium | 2 | 2017 | 1061 | 0.41 | Why? |
| Simulation Training | 1 | 2020 | 957 | 0.40 | Why? |
| Terminal Care | 1 | 2018 | 928 | 0.34 | Why? |
| Cardiac Surgical Procedures | 2 | 2017 | 1931 | 0.33 | Why? |
| Critical Illness | 6 | 2018 | 17281 | 0.32 | Why? |
| Intensive Care Units | 9 | 2020 | 29594 | 0.31 | Why? |
| Critical Care | 9 | 2020 | 14081 | 0.29 | Why? |
| Dysbiosis | 2 | 2021 | 685 | 0.27 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.27 | Why? |
| Curriculum | 1 | 2017 | 3083 | 0.26 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.26 | Why? |
| Gastrointestinal Microbiome | 3 | 2021 | 1961 | 0.25 | Why? |
| Infection Control | 3 | 2021 | 23131 | 0.24 | Why? |
| Aging | 1 | 2018 | 3581 | 0.22 | Why? |
| Education, Medical | 1 | 2017 | 2461 | 0.21 | Why? |
| Microtubule-Associated Proteins | 1 | 2021 | 187 | 0.20 | Why? |
| Communication | 1 | 2017 | 5206 | 0.20 | Why? |
| Sufentanil | 1 | 2018 | 8 | 0.19 | Why? |
| Hong Kong | 7 | 2021 | 3361 | 0.19 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.19 | Why? |
| Pain, Procedural | 1 | 2018 | 51 | 0.18 | Why? |
| Lorazepam | 1 | 2018 | 70 | 0.18 | Why? |
| Morphine | 1 | 2018 | 71 | 0.18 | Why? |
| beta-Lactamase Inhibitors | 1 | 2019 | 104 | 0.18 | Why? |
| Adsorption | 1 | 2019 | 261 | 0.18 | Why? |
| Students, Medical | 1 | 2017 | 4032 | 0.18 | Why? |
| Social Media | 1 | 2020 | 5798 | 0.18 | Why? |
| Midazolam | 1 | 2018 | 79 | 0.18 | Why? |
| Systems Theory | 1 | 2017 | 20 | 0.18 | Why? |
| Lysosomes | 1 | 2021 | 416 | 0.17 | Why? |
| Hemofiltration | 1 | 2019 | 155 | 0.17 | Why? |
| Fentanyl | 1 | 2018 | 142 | 0.16 | Why? |
| Dexmedetomidine | 1 | 2018 | 130 | 0.16 | Why? |
| Laryngoscopy | 1 | 2021 | 413 | 0.15 | Why? |
| Propofol | 1 | 2018 | 172 | 0.15 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.15 | Why? |
| Gastrointestinal Tract | 2 | 2021 | 1113 | 0.15 | Why? |
| Hyperbaric Oxygenation | 1 | 2018 | 268 | 0.14 | Why? |
| Environmental Pollution | 1 | 2018 | 344 | 0.14 | Why? |
| Communication Barriers | 1 | 2017 | 246 | 0.14 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.13 | Why? |
| Efficiency, Organizational | 1 | 2017 | 482 | 0.13 | Why? |
| Respiration, Artificial | 3 | 2017 | 22116 | 0.13 | Why? |
| Cannula | 1 | 2018 | 750 | 0.12 | Why? |
| Professional-Patient Relations | 1 | 2017 | 426 | 0.12 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.11 | Why? |
| Pneumonia, Bacterial | 1 | 2018 | 843 | 0.11 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.11 | Why? |
| Airway Management | 1 | 2021 | 1298 | 0.11 | Why? |
| Cross Infection | 1 | 2013 | 8675 | 0.11 | Why? |
| Humans | 32 | 2021 | 930598 | 0.10 | Why? |
| Patient Admission | 2 | 2017 | 5250 | 0.10 | Why? |
| Bacteria | 1 | 2021 | 1897 | 0.10 | Why? |
| Interpersonal Relations | 1 | 2017 | 926 | 0.10 | Why? |
| Hand Hygiene | 1 | 2020 | 1493 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.09 | Why? |
| Patient Readmission | 1 | 2017 | 1543 | 0.09 | Why? |
| Workplace | 1 | 2020 | 2075 | 0.08 | Why? |
| Quality Improvement | 1 | 2020 | 2435 | 0.08 | Why? |
| Masks | 2 | 2020 | 8528 | 0.08 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.08 | Why? |
| Feces | 1 | 2020 | 4235 | 0.08 | Why? |
| Emotions | 1 | 2018 | 2418 | 0.08 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.07 | Why? |
| Health Care Rationing | 1 | 2020 | 2558 | 0.07 | Why? |
| Intubation, Intratracheal | 1 | 2021 | 3962 | 0.07 | Why? |
| Qualitative Research | 1 | 2017 | 4337 | 0.07 | Why? |
| Length of Stay | 3 | 2017 | 11042 | 0.07 | Why? |
| Nurses | 1 | 2020 | 2285 | 0.07 | Why? |
| Triage | 2 | 2020 | 7151 | 0.06 | Why? |
| Europe | 1 | 2020 | 12702 | 0.06 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.06 | Why? |
| Transferases | 1 | 2021 | 28 | 0.06 | Why? |
| Referral and Consultation | 1 | 2017 | 4816 | 0.05 | Why? |
| Metapneumovirus | 1 | 2003 | 465 | 0.05 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.05 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.05 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.05 | Why? |
| Ticarcillin | 1 | 2019 | 1 | 0.05 | Why? |
| Clavulanic Acids | 1 | 2019 | 2 | 0.05 | Why? |
| Cell Cycle | 1 | 2021 | 329 | 0.05 | Why? |
| Adult | 13 | 2021 | 244371 | 0.05 | Why? |
| Acrylic Resins | 1 | 2019 | 48 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.05 | Why? |
| Venous Pressure | 1 | 1998 | 5 | 0.05 | Why? |
| Male | 14 | 2021 | 367725 | 0.05 | Why? |
| Communicable Diseases, Emerging | 2 | 2003 | 2523 | 0.05 | Why? |
| Central Venous Pressure | 1 | 1998 | 24 | 0.05 | Why? |
| Iliac Vein | 1 | 1998 | 21 | 0.05 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.04 | Why? |
| Cholesterol | 1 | 2021 | 660 | 0.04 | Why? |
| DNA, Bacterial | 1 | 2021 | 835 | 0.04 | Why? |
| Gastric Mucosa | 1 | 1997 | 141 | 0.04 | Why? |
| Female | 13 | 2021 | 380317 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2003 | 12361 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2019 | 1027 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| DNA | 1 | 2021 | 778 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.04 | Why? |
| Pain Measurement | 1 | 2018 | 533 | 0.04 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.04 | Why? |
| Stress, Psychological | 1 | 2018 | 10231 | 0.04 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.03 | Why? |
| Epidemiologic Studies | 1 | 2017 | 554 | 0.03 | Why? |
| APACHE | 1 | 2017 | 682 | 0.03 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.03 | Why? |
| Aged | 10 | 2020 | 215776 | 0.03 | Why? |
| Gram-Negative Bacteria | 1 | 2018 | 473 | 0.03 | Why? |
| Autophagy | 1 | 2021 | 960 | 0.03 | Why? |
| RNA-Binding Proteins | 1 | 2021 | 1022 | 0.03 | Why? |
| RNA | 1 | 2021 | 1278 | 0.03 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.03 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.03 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Disease Outbreaks | 3 | 2004 | 27595 | 0.03 | Why? |
| New Zealand | 1 | 2017 | 2073 | 0.03 | Why? |
| Patient Transfer | 1 | 2017 | 898 | 0.03 | Why? |
| Carbon Dioxide | 1 | 1997 | 917 | 0.03 | Why? |
| Hospital Bed Capacity | 1 | 2017 | 1300 | 0.02 | Why? |
| Cooperative Behavior | 1 | 2017 | 1216 | 0.02 | Why? |
| Ischemia | 1 | 1997 | 901 | 0.02 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.02 | Why? |
| Quality of Health Care | 1 | 2017 | 1948 | 0.02 | Why? |
| Cognitive Dysfunction | 1 | 2017 | 1389 | 0.02 | Why? |
| Frailty | 1 | 2017 | 1432 | 0.02 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Australia | 1 | 2017 | 6306 | 0.02 | Why? |
| Surgical Procedures, Operative | 1 | 2018 | 2662 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2020 | 5002 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Aged, 80 and over | 3 | 2018 | 88759 | 0.01 | Why? |
| SARS Virus | 1 | 2003 | 13021 | 0.01 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.01 | Why? |
| Allied Health Personnel | 1 | 2003 | 416 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Vena Cava, Superior | 1 | 1998 | 30 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Airway Resistance | 1 | 1998 | 83 | 0.01 | Why? |
| Splanchnic Circulation | 1 | 1997 | 37 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Coronavirus | 2 | 2003 | 18339 | 0.01 | Why? |
| Manometry | 1 | 1997 | 91 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Partial Pressure | 1 | 1997 | 279 | 0.01 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Pressure | 1 | 1998 | 289 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Radiography | 1 | 2003 | 1576 | 0.01 | Why? |
| Abdomen | 1 | 1998 | 424 | 0.01 | Why? |
| Blood Pressure Determination | 1 | 1998 | 450 | 0.01 | Why? |
| Hydrogen-Ion Concentration | 1 | 1997 | 993 | 0.01 | Why? |
| Macaca mulatta | 1 | 2003 | 3716 | 0.01 | Why? |
| Methylprednisolone | 1 | 2004 | 2107 | 0.01 | Why? |
| Anti-Infective Agents | 1 | 2004 | 1766 | 0.01 | Why? |
| Cells, Cultured | 1 | 2003 | 5835 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Positive-Pressure Respiration | 1 | 1998 | 1160 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2003 | 7220 | 0.01 | Why? |
| Glucocorticoids | 1 | 2004 | 4431 | 0.01 | Why? |
| Monitoring, Physiologic | 1 | 1998 | 1956 | 0.01 | Why? |
| Double-Blind Method | 1 | 1998 | 5988 | 0.00 | Why? |
| ROC Curve | 1 | 1997 | 6024 | 0.00 | Why? |
| Pneumonia | 1 | 2003 | 5652 | 0.00 | Why? |
| Survival Rate | 1 | 1997 | 9206 | 0.00 | Why? |
| Antibodies, Viral | 2 | 2003 | 51949 | 0.00 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2003 | 9706 | 0.00 | Why? |
| Treatment Outcome | 1 | 2004 | 51732 | 0.00 | Why? |
| Animals | 1 | 2003 | 78931 | 0.00 | Why? |
Joynt's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(189)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(131)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_